| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/09/2013 | CN103340804A Special wet tissue for cleaning and disinfecting nipples of female in lactation period |
| 10/09/2013 | CN103340800A Chinese herbal medicine toothpaste and preparation method thereof |
| 10/09/2013 | CN103340777A Spot-removing cream |
| 10/09/2013 | CN103340767A Rose water concentrated liquor processing method |
| 10/09/2013 | CN103340764A Shampoo containing tea seed cake extract and preparation method thereof |
| 10/09/2013 | CN103340219A Chinese herbal medicine pesticide and preparation method thereof |
| 10/09/2013 | CN103087156B Foot and mouth disease virus (FMDV) antigen polypeptide and vaccine |
| 10/09/2013 | CN102936570B Azadirachtaindica endogeny xylaria |
| 10/09/2013 | CN102920943B Traditional Chinese medicine for treating retroperitoneal abscess |
| 10/09/2013 | CN102861310B Medicine for hepatitis B |
| 10/09/2013 | CN102846577B Enteric tablet containing erythromycin cydocarbonate |
| 10/09/2013 | CN102846564B A cefprozil tablet and its preparation method |
| 10/09/2013 | CN102805809B Oral liquid for treating infant myocarditis |
| 10/09/2013 | CN102702333B Drug-resistant pathogen infection resistant polypeptide and uses thereof |
| 10/09/2013 | CN102657763B Externally used composition for treating mumps, lymphnoditis or prostatitis |
| 10/09/2013 | CN102649961B Aptamer sequence of hepatitis B virus (HBV) core antigen and application of nucleic aptamer sequence |
| 10/09/2013 | CN102628053B Construction and application of recombinant Chicken Marek's Disease Virus SC9-1 strain and SC9-2 strain |
| 10/09/2013 | CN102600272B Traditional Chinese medicine for treatment of orthopedic disease |
| 10/09/2013 | CN102579364B Sustained or controlled release microsphere of valnemulin/valnemulin salts and preparation method thereof |
| 10/09/2013 | CN102533772B Anti-HBV (Hepatitis B Virus) decoy aptamer and screening method thereof |
| 10/09/2013 | CN102533669B 鸭byd病毒灭活疫苗及其制备方法 Duck byd inactivated virus vaccines and preparation method |
| 10/09/2013 | CN102533583B Antiviral actinomycete HA10211 and application thereof |
| 10/09/2013 | CN102526521B Traditional Chinese medicine composition powder for treating nephropathogenic infectious bronchitis in chicken |
| 10/09/2013 | CN102499983B Application of HepG2.2.15 cell autophagy corpuscle in preparing hepatitis b virus (HBV) therapeutic vaccines |
| 10/09/2013 | CN102397401B Compound propolis pure traditional Chinese medicine composition for treating birds necrotic enteritis and preparation method thereof |
| 10/09/2013 | CN102380093B Method for producing newcastle disease living vaccines by utilizing passage fibroblasts |
| 10/09/2013 | CN102296044B Unmarked gene-deleted and attenuated mutant strain of vibrio alginolyticus wild strain, and preparation and use thereof |
| 10/09/2013 | CN102274206B Application of germacrone in preparation of medicament for treating or preventing influenza viruses |
| 10/09/2013 | CN102219725B Benzohetercyclic compound as well as preparation method and applications thereof |
| 10/09/2013 | CN102198264B Beta-defensin 15 of specific antibacterial peptides of rat epididymis and application thereof |
| 10/09/2013 | CN102134279B Fusion protein and encoding gene thereof as well as application of fusion protein |
| 10/09/2013 | CN102061322B Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner |
| 10/09/2013 | CN101352464B Quality control method of Chinese medicinal composition |
| 10/08/2013 | US8552198 Benzimidazole compound crystal |
| 10/08/2013 | US8552147 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 10/08/2013 | US8552145 Vaccine for modulating between T1 and T2 immune responses |
| 10/08/2013 | US8552064 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
| 10/08/2013 | US8551965 Anti-viral pyrimidine nucleoside analogues |
| 10/08/2013 | US8551943 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 10/08/2013 | US8551942 Lyophilized anti-fungal compositions |
| 10/08/2013 | US8551936 Defensin-antigen fusion proteins |
| 10/08/2013 | US8551522 Sustained-release formulation |
| 10/08/2013 | CA2653933C Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 10/08/2013 | CA2594582C Valnemulin salts with organic acids |
| 10/08/2013 | CA2501939C Novel immunogenic proteins of leptospira |
| 10/08/2013 | CA2479304C Virus-like particles of human papillomavirus |
| 10/08/2013 | CA2456007C Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation |
| 10/08/2013 | CA2380753C Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 10/08/2013 | CA2349839C Ucp5 |
| 10/08/2013 | CA2238893C Il-13 receptor polypeptide |
| 10/04/2013 | CA2811762A1 Vaccine composition |
| 10/03/2013 | WO2013149190A1 Pharmaceutical compositions and methods for treatment of fungal infections |
| 10/03/2013 | WO2013149147A1 Mesylate salt forms of a potent hcv inhibitor |
| 10/03/2013 | WO2013149136A1 ISOXAZOLE β-LACTAMASE INHIBITORS |
| 10/03/2013 | WO2013149121A1 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
| 10/03/2013 | WO2013149030A2 Use of thymosin alpha for the treatment of sepsis |
| 10/03/2013 | WO2013149010A1 Enhanced antimicrobial lytic activity of a chimeric ply187 endolysin |
| 10/03/2013 | WO2013148857A1 Triazole derivatives as hsp90 inhibitors |
| 10/03/2013 | WO2013148620A1 Benzofuran derivatives for the treatment of hepatitis c |
| 10/03/2013 | WO2013148269A1 Methods and compositions for reducing the proliferation of gram positive bacteria |
| 10/03/2013 | WO2013148174A1 New anti-mycobacterial drugs against tuberculosis |
| 10/03/2013 | WO2013148072A1 Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections |
| 10/03/2013 | WO2013148067A1 3,28-disubstituted betulinic acid derivatives as anti-hiv agents |
| 10/03/2013 | WO2013147585A1 A composition having antiviral activity against flavivirus |
| 10/03/2013 | WO2013147584A1 Antiviral composition against flavivirus |
| 10/03/2013 | WO2013147513A1 Composition for preventing or treating immune-related disease and oxidative-stress-related disease |
| 10/03/2013 | WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell |
| 10/03/2013 | WO2013147082A1 Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient |
| 10/03/2013 | WO2013146480A1 Gene introduction method |
| 10/03/2013 | WO2013146380A1 Coating composition and medical device |
| 10/03/2013 | WO2013145750A1 Capsule pharmaceutical preparation |
| 10/03/2013 | WO2013145749A1 Capsule preparation |
| 10/03/2013 | WO2013144247A1 Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles |
| 10/03/2013 | WO2013144193A1 Combination therapy for treating hcv infection in specific patient subgenotype sub-population |
| 10/03/2013 | WO2013144129A1 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
| 10/03/2013 | WO2013144119A1 Potent synergistic effect of doxycycline with fluconazole against candida albicans |
| 10/03/2013 | WO2013143581A1 Combination therapy for treating hcv infection in specific patient subgenotype sub-population |
| 10/03/2013 | WO2013143501A1 Hydrate of cyclopeptide compound as well as preparation method and use thereof |
| 10/03/2013 | WO2013143499A1 High-purity cyclopeptide crystal as well as preparation method and use thereof |
| 10/03/2013 | WO2013143497A1 High purity cyclopeptide compound as well as preparation method and use thereof |
| 10/03/2013 | WO2013143477A1 1,4-dihydroxy-6-methyl-2-pyridone compound, and preparation method and application thereof |
| 10/03/2013 | WO2013143412A1 Pharmaceutical compositions |
| 10/03/2013 | WO2013143322A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection |
| 10/03/2013 | WO2013117503A3 Pi3k inhibitors for treating fibrotic diseases |
| 10/03/2013 | US20130261294 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound |
| 10/03/2013 | US20130260453 Method for expression of small rna molecules within a cell |
| 10/03/2013 | US20130259889 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 10/03/2013 | US20130259886 Broadly protective influenza t-cell vaccine against diverse influenza a viruses |
| 10/03/2013 | US20130259849 Enhanced Antimicrobial Lytic Activity of a Chimeric Ply187 Endolysin |
| 10/02/2013 | EP2643324A1 Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]-benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with phenyl derivatives |
| 10/02/2013 | EP2643323A1 Compounds for treating respiratory syncytial virus infections |
| 10/02/2013 | EP2643307A1 Nitrobenzothiazole derivatives and use thereof for treating tuberculosis |
| 10/02/2013 | EP2643020A1 A drug delivery device |
| 10/02/2013 | EP2643015A1 Compositions and methods |
| 10/02/2013 | EP2643006A1 Oligosaccharide composition for treating acute respiratory tract infections |
| 10/02/2013 | EP2643003A1 Vaginal composition based on alkyl polyglucosides |
| 10/02/2013 | EP2642996A2 Pharmaceutical compositions |
| 10/02/2013 | EP2642992A1 Compounds and their use |
| 10/02/2013 | DE102004037611B4 Induzierbare Genexpression Inducible gene expression |